Abstract
We would like to thank Dr Maytin and colleagues for highlighting some important issues with regard to the Fidelis lead and its appropriate management. The experience that we reported is the only comprehensive experience regarding the Fidelis lead and complications related to its revision.1 The complication classification that we used is based on prior reports on complications due to device advisories or replacements.2,3 Our study was not designed specifically to examine complications due to transvenous lead extraction, so the system of classification suggested by Maytin et al would not be applicable. If traction was attempted, but the lead was abandoned, the patient was classified as lead abandoned. The data reported by Maytin et al4 have significant potential referral bias, as patients with a higher degree of comorbid illness may not have been referred. In …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
